HomeXBIO • NASDAQ
add
Xenetic Biosciences Inc
Previous close
$3.38
Day range
$2.82 - $3.28
Year range
$1.90 - $13.93
Market cap
7.19M USD
Avg Volume
27.31K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 766.30K | 18.11% |
Operating expense | 1.39M | -20.52% |
Net income | -579.08K | 45.09% |
Net profit margin | -75.57 | 53.50% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.88M | 27.87% |
Total assets | 8.36M | 21.19% |
Total liabilities | 968.02K | 8.25% |
Total equity | 7.40M | — |
Shares outstanding | 2.29M | — |
Price to book | 1.05 | — |
Return on assets | -23.19% | — |
Return on capital | -27.44% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -579.08K | 45.09% |
Cash from operations | -242.68K | 63.99% |
Cash from investing | — | — |
Cash from financing | 4.00M | — |
Net change in cash | 3.76M | 658.17% |
Free cash flow | 131.01K | 112.96% |
About
Founded
1997
Headquarters
Website
Employees
2
